Adriana Patricia Tagliaferro, Ph.D.
Dr. Adriana Tagliaferro received her Ph.D. in Neuroscience from the University of Buenos Aires. She is a broadly trained neuroanatomist and histologist who obtained most of her experience conducting research at the National Institute on Drug Abuse (NIDA – NIH) and Columbia University. Her research interest has focused on the study of substance abuse and its effects on the structure and function of the brain as well as the identification of new strategies for the treatment of Parkinson’s disease. Dr. Tagliaferro is currently an associate editor of the scientific journal Advances in Drug and Alcohol Research (ADAR).
Selected Publications
Qing-Rong L., Canseco-Alba A., Zhang H-Y., Tagliaferro P., Chung M., Dennis E., Sanabria B., Schanz N., Escosteguy-Neto J., Ishiguro H., Lin Z., Sgro S., Leonard C., Santos-Junior J., Gardner E., Egan J., Lee J., Xi J., Onaivi E. Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference. Scientific Report. 7(1):17410. doi: 10.1038/s41598-017-17796-y. 2017
Tagliaferro P and Burke RE. Review: retrograde axonal degeneration in Parkinson disease. Journal of Parkinson’s Disease. 6:1-15. 2016.
Tagliaferro P, Kareva T, Oo TF, Yarygina O, Kholodilov N, Burke R. An early pathology in a hLRRK2(R1441G) transgenic model of Parkinson disease. Neurobiology of Disease. 82:359-371. 2015.
Chen X, Tagliaferro P, Kareva T, Yarygina O, Kholodilov N, Burke R. Neurotrophic effects of Serum- and Glucocorticoid-inducible Kinase (SGK) on adult murine mesencephalic dopamine neurons. Journal of Neuroscience. 32:11299-11308. 2012.
Tagliaferro P and Morales M. "Synapses between axon terminals containing corticotropin releasing factor and dopaminergic neurons are predominantly glutamatergic in the ventral tegmental area". Journal of Comparative Neurology 506(4):616-626. 2008.